Children's Hospital Oakland Research Institute, Oakland, CA, USA.
Faculty of Medicine, University of Oslo, Oslo, Norway.
Cardiovasc Diabetol. 2017 Jul 6;16(1):85. doi: 10.1186/s12933-017-0570-2.
Patients with type 1 diabetes (T1D) are at increased risk of cardiovascular disease (CVD). Measures of high-density lipoprotein (HDL) function provide a better risk estimate for future CVD events than serum levels of HDL cholesterol. The objective of this study was to evaluate HDL function in T1D patients shortly after disease onset compared with healthy control subjects.
Participants in the atherosclerosis and childhood diabetes study were examined at baseline and after 5 years. At baseline, the cohort included 293 T1D patients with a mean age of 13.7 years and mean HbA1c of 8.4%, along with 111 healthy control subjects. Their HDL function, quantified by HDL-apoA-I exchange (HAE), was assessed at both time points. HAE is a measure of HDL's dynamic property, specifically its ability to release lipid-poor apolipoprotein A-I (apoA-I), an essential step in reverse cholesterol transport.
The HAE-apoA-I ratio, reflecting the HDL function per concentration unit apoA-I, was significantly lower in the diabetes group both at baseline, 0.33 (SD = 0.06) versus 0.36 (SD = 0.06) %HAE/mg/dL, p < 0.001 and at follow-up, 0.34 (SD = 0.06) versus 0.36 (SD = 0.06) %HAE/mg/dL, p = 0.003. HAE-apoA-I ratio was significantly and inversely correlated with HbA1c in the diabetes group. Over the 5 years of the study, the mean HAE-apoA-I ratio remained consistent in both groups. Individual changes were less than 15% for half of the study participants.
This study shows reduced HDL function, quantified as HAE-apoA-I ratio, in children and young adults with T1D compared with healthy control subjects. The differences in HDL function appeared shortly after disease onset and persisted over time.
1 型糖尿病(T1D)患者患心血管疾病(CVD)的风险增加。高密度脂蛋白(HDL)功能的测量比血清 HDL 胆固醇水平提供了对未来 CVD 事件更好的风险估计。本研究的目的是评估 T1D 患者在疾病发病后不久与健康对照组相比 HDL 功能。
动脉粥样硬化和儿童糖尿病研究的参与者在基线和 5 年后进行了检查。在基线时,该队列包括 293 名平均年龄为 13.7 岁、平均 HbA1c 为 8.4%的 T1D 患者,以及 111 名健康对照组。他们的 HDL 功能,通过 HDL-apoA-I 交换(HAE)来量化,在两个时间点都进行了评估。HAE 是 HDL 动态特性的一种衡量标准,特别是其释放富含脂质的载脂蛋白 A-I(apoA-I)的能力,这是胆固醇逆转运的关键步骤。
在糖尿病组中,HAE-apoA-I 比值(反映每单位 apoA-I 的 HDL 功能)在基线时明显较低,分别为 0.33(SD=0.06)%HAE/mg/dL 和 0.36(SD=0.06)%HAE/mg/dL,p<0.001,在随访时分别为 0.34(SD=0.06)%HAE/mg/dL 和 0.36(SD=0.06)%HAE/mg/dL,p=0.003。HAE-apoA-I 比值与糖尿病组的 HbA1c 呈显著负相关。在研究的 5 年期间,两组的平均 HAE-apoA-I 比值保持一致。研究参与者中有一半的个体变化小于 15%。
本研究显示,与健康对照组相比,T1D 患儿和年轻成人的 HDL 功能,表现为 HAE-apoA-I 比值降低。HDL 功能的差异在疾病发病后不久就出现,并随着时间的推移而持续存在。